Evidence map›Paper›PMID 41575604›Full record

ArticleDermatology and therapy2026

Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.

Tiago Torres, Siddhartha Sood, Orhan Yilmaz, Ronald B Vender, Vimal H Prajapati, Luis Puig, Matteo Megna, Angelo Valerio Marzano, Paolo Gisondi, Jose Manuel Carrascosa and 17 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Tiago TorresDepartment of Dermatology, Centro Hospitalar de Santo António, Centro Hospitalar Universitário do Porto, Largo do Prof. Abel Salazar S/N, 4099-001, Porto, Portugal. torres.tiago@outlook.com.ORCID http://orcid.org/0000-0003-0404-0870
Siddhartha SoodTemerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Orhan YilmazCollege of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Ronald B VenderDivision of Dermatology, McMaster University, Hamilton, ON, Canada.
Vimal H PrajapatiProbity Medical Research, Waterloo, Canada.
Luis PuigDepartment of Dermatology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain.
Matteo MegnaSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Angelo Valerio MarzanoDermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Paolo GisondiDepartment of Dermatology, University of Verona, Verona, Italy.
Jose Manuel CarrascosaServicio de Dermatología, Hospital Universitari Germans Trias i Pujol, IGTP, UAB Badalona, Barcelona, Spain.
Esteban DaudenDepartment of Dermatology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain.
Mar Llamas-VelascoDepartment of Dermatology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain.
Anna BalatoUnit of Dermatology, University of Campania Luigi Vanvitelli, Naples, Italy.
Barbara Guerra LealInstituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
Francesca PrignanoDepartment of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Francesco BellinatoDepartment of Dermatology, University of Verona, Verona, Italy.
Gianmarco SilviDepartment of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Eugenia Veronica Di BrizziUnit of Dermatology, University of Campania Luigi Vanvitelli, Naples, Italy.
Luca PotestioSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Carlo Giovanni CarreraDermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Anna López-FerrerDepartment of Dermatology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain.
Elena Del-AlcazarServicio de Dermatología, Hospital Universitari Germans Trias i Pujol, IGTP, UAB Badalona, Barcelona, Spain.
Asfandyar MuftiDivision of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Lara Valeska MaulDepartment of Dermatology, University Hospital Basel, Basel, Switzerland.
Stefano PiasericoDepartment of Dermatology, University of Padua, Padua, Italy.
Julia-Tatjana MaulDepartment of Dermatology, University Hospital Zürich, Zurich, Switzerland.
Jensen YeungProbity Medical Research, Waterloo, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41575604
PMCPMC12936243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.